clinical trial · NCT05381753
Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World
Gastrointestinal Stromal TumorsAvapritinibTyrosine kinase inhibitors other than avapritinib ( imatinib, sunitinib, et al )
brief summary
This study is an observational, multicenter, Real-word study to evaluate the safety and clinical efficacy of avapritinib in Chinese subjects with GIST.
started
Aug 29, 2022
primary completion
Sep 30, 2024
completion
Sep 30, 2024
last updated
Feb 11, 2026
official title
A National Multicenter, Noninterventional Clinical Study Evaluating the Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol